BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Business

  111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

  111, Inc. announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.

  March 21, 2024

   · 

  27 min read
• Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024

  Affimed N.V. announced that it will release full year 2023 results and corporate update on March 28, 2024.

  March 21, 2024

   · 

  3 min read
• Business

  Castellum, Inc. Announces 2023 Financial Results

  Castellum, Inc. announces its results for the year ended December 31, 2023.

  March 21, 2024

   · 

  6 min read
• NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine

  NMD Pharma A/S announces the peer-reviewed publication of comprehensive data sets demonstrating, for the first time, the ability of CIC-1 inhibition to restore muscle function in patients suffering from myasthenia gravis and in animal models of MG.

  March 21, 2024

   · 

  4 min read
• Pharm Country

  TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

  TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced the U.S. launch of LIQUIFIX FIX8™ Laparoscopic and LIQUIFIX Precision™ Open Hernia Mesh Fixation Devices.

  March 21, 2024

   · 

  7 min read
• Innate Pharma Reports Full Year 2023 Financial Results and Business Update

  Innate Pharma SA reported its consolidated financial results for the year ending December 31, 2023.

  March 21, 2024

   · 

  47 min read
• Genflow Biosciences PLC Announces Notification of Major Holdings

  Genflow Biosciences PLC Announces Notification of Major Holdings.

  March 21, 2024

   · 

  2 min read
• Business

  X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

  X4 Pharmaceuticals, a company driven to improve the lives of people with rare diseases of the immune system, reported financial results for the fourth quarter and full year ended December 31, 2023, and highlighted key 2023 events and expected upcoming milestones.

  March 21, 2024

   · 

  11 min read
• Business

  Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024Live Conference Call and Webcast at 8:30 a.m. ET

  Agile Therapeutics, Inc., a women’s healthcare company, announced it will report fourth quarter and full year 2023 financial results before the market opens on Thursday, March 28, 2024.

  March 21, 2024

   · 

  1 min read
• Genetown

  BostonGene Announces Participation at the United States and Canadian Academy of Pathology 113th Annual Meeting

  BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced it will participate in the United States and Canadian Academy of Pathology (USCAP) 113th Annual Meeting, the largest gathering of pathologists in the world.

  March 21, 2024

   · 

  2 min read